Enovis | ENOV - Cost Of Sales

Stock Price
23.63
Daily Change
1.11 4.93%
Monthly
-4.18%
Yearly
-30.95%
Q2 Forecast
21.96

Enovis reported $271.52M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Alcidion AUD 6.82M 1.16M Dec/2025
Ambu A/S DKK 611M 24M Dec/2025
Amplifon EUR 460.17M 14.78M Sep/2025
Apollo Hospitals Enterprise Ltd INR 36.02B 1.4B Dec/2025
Coloplast 2.31B 110M Dec/2025
Convatec Group USD 515.3M 270.15M Dec/2024
Diasorin EUR 99.64M 4.71M Sep/2025
Enovis USD 271.52M 7.83M Dec/2025
Gulf Medical Proj AED 151.05M 11.52M Dec/2025
Hoya 33.74B 138.33B Dec/2025
Med Life RON 283.78M 123.71M Sep/2025
Oriola-kd EUR 461.6M 35.5M Dec/2025
Rede D'or Sao Luiz BRL 6.29B 4.77B Dec/2025
Siemens Healthineers EUR 3.33B 622M Dec/2025
Sonova Holding CHF 539.4M 11.5M Dec/2025